Walleye Capital’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.6K Sell
400
-9,400
-96% -$966K ﹤0.01% 3977
2025
Q4
$933K Sell
9,800
-6,300
-39% -$635K ﹤0.01% 2492
2025
Q3
$1.59M Sell
16,100
-32,000
-67% -$3.42M 0.01% 1750
2025
Q2
$5.12M Buy
48,100
+22,400
+87% +$2.26M 0.02% 854
2025
Q1
$2.34M Sell
25,700
-16,400
-39% -$1.84M 0.01% 1299
2024
Q4
$4.8M Buy
42,100
+18,300
+77% +$2.09M 0.01% 1108
2024
Q3
$2.83M Buy
23,800
+23,100
+3,300% +$2.12M 0.01% 1634
2024
Q2
$56.3K Sell
700
-7,700
-92% -$704K ﹤0.01% 4897
2024
Q1
$775K Sell
8,400
-54,600
-87% -$5.24M ﹤0.01% 2828
2023
Q4
$6.65M Buy
63,000
+62,300
+8,900% +$6.28M 0.01% 926
2023
Q3
$76K Sell
700
-2,300
-77% -$254K ﹤0.01% 4058
2023
Q2
$324K Sell
3,000
-1,200
-29% -$135K ﹤0.01% 2729
2023
Q1
$523K Buy
+4,200
New +$577K 0.01% 1676
2022
Q4
Sell
-800
Closed -$108K 3196
2022
Q3
$108K Buy
+800
New +$122K ﹤0.01% 2389

Other funds holding BNTX

Walleye Capital's BNTX Position: Q1 2026 in Review

Walleye Capital reduced its BioNTech (BNTX) stake by 48% in Q1 2026, selling an estimated $848K and leaving 9,066 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

Walleye Capital first reported a position in BNTX in Q3 2023 and has held it in 10 quarters since. The position peaked at $6.93M in Q2 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Walleye Capital held 9,066 shares of BioNTech worth $806K as of Q1 2026.
  • Walleye Capital sold 8,253 BioNTech shares in Q1 2026, an estimated $848K.
  • BioNTech made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2274 holding.
  • Walleye Capital first reported a position in BioNTech in Q3 2023 and has held it in 10 quarters since.
  • Walleye Capital's BioNTech position peaked at $6.93M in Q2 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.